Literature DB >> 6824812

Effects of antiarrhythmic drugs on ventricular fibrillation thresholds of normal and ischaemic myocardium in the anaesthetized rat.

R J Marshall, A W Muir, E Winslow.   

Abstract

1 The effects of agents which produce membrane stabilization (class I), beta 1-adrenoceptor blockade (class II), prolongation of the cardiac action potential (class III) or inhibition of the slow inward current (class IV) were investigated for their ability to increase the ventricular fibrillation threshold (VFT) or to modify the fall in VFT consequent upon coronary artery ligation in the anaesthetized rat. 2 The class I agent, Org6001, increased VFT of normal myocardium and in lower doses reduced the postligation fall in VFT. 3 The class II agent, metoprolol, failed to increase VFT of normal myocardium but reduced the postligation fall. 4 The class III agent, melperone, increased VFT of both normal and ischaemic myocardium whereas the class IV agent, nifedipine failed to influence VFT in either region. 5 Bepridil (class I and IV) was similar to Org6001 and sotalol (class II and III) in that it increased VFT of normal myocardium and in lower doses reduced the postligation fall in VFT. 6 Measurement of VFT before and after coronary artery ligation in the rat constitutes a rapid and reproducible screen to detect antifibrillatory activity. 7 The results also suggest that in the rat, the low currents used (approximately 400 microA) do not release substantial quantities of catecholamines whereas these may be released by coronary artery ligation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824812      PMCID: PMC2044784          DOI: 10.1111/j.1476-5381.1983.tb09377.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Investigations to characterize a new anti-arrhythmic drug, ORG 6001 including a simple test for calcium antagonism.

Authors:  L A Salako; V Williams; J H Wittig
Journal:  Br J Pharmacol       Date:  1976-06       Impact factor: 8.739

2.  Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heart.

Authors:  W F Lubbe; M L McFadyen; C A Muller; M Worthington; L H Opie
Journal:  Am J Cardiol       Date:  1979-03       Impact factor: 2.778

3.  Release of autonomic neuromediators by local ventricular electrical stimulation.

Authors:  D E Euler
Journal:  Am J Physiol       Date:  1980-06

4.  Development of a severe model of early coronary artery ligation-induced dysrhythmias in the anaesthetized rat.

Authors:  R J Marshall; A W Muir; E Winslow
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

5.  The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

6.  Antidysrhythmic and electrophysiological effects of a new antianginal agent, bepridil.

Authors:  K A Kane; E Winslow
Journal:  J Cardiovasc Pharmacol       Date:  1980       Impact factor: 3.105

7.  Comparative antidysrhythmic and haemodynamic effects of orally or intravenously administered mexiletine and ORG 6001 in the anaesthetized rat.

Authors:  R J Marshall; A W Muir; E Winslow
Journal:  Br J Pharmacol       Date:  1981-10       Impact factor: 8.739

8.  Detailed activation sequence in the region of electrically induced ventricular fibrillation in dogs.

Authors:  K Harumi; G R Smith; J A Abildskov; M J Burgess; R L Lux; R F Wyatt
Journal:  Jpn Heart J       Date:  1980-07

9.  Differential actions on rabbit nodal, atrial, Purkinje cell and ventricular potentials of melperone, a bradycardic agent delaying repolarization: effects of hypoxia.

Authors:  J S Millar; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739

10.  Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size.

Authors:  C Clark; M I Foreman; K A Kane; F M McDonald; J R Parratt
Journal:  J Pharmacol Methods       Date:  1980-06
View more
  6 in total

1.  Blockade by antiarrhythmic drugs of glibenclamide-sensitive K+ channels in Xenopus oocytes.

Authors:  H Sakuta; K Okamoto; Y Watanabe
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

2.  Bepridil differentially inhibits two delayed rectifier K(+) currents, I(Kr) and I(Ks), in guinea-pig ventricular myocytes.

Authors:  J C Wang; T Kiyosue; K Kiriyama; M Arita
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

Review 3.  Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  B N Singh; P Deedwania; K Nademanee; A Ward; E M Sorkin
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

Review 4.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

5.  Antiarrhythmic actions of verapamil against ischaemic arrhythmias in the rat.

Authors:  M J Curtis; B A MacLeod; M J Walker
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

Review 6.  Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation--tentative prophylactic properties of vagus nerve stimulation on malignant arrhythmias in heart failure.

Authors:  Kieran E Brack; James Winter; G André Ng
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.